Shedding light on corticosteroid-resistant type 2-high severe asthma

被引：5
作者：
Chung, Kian Fan [1 ,2 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England
[2] Royal Brompton & Harefield NHS Trust, London, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 01期
关键词：
Asthma; type; 2; inflammation; corticosteroid resistance; eosinophils; INSENSITIVITY; INFLAMMATION;
D O I：
10.1016/j.jaci.2018.11.002
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [31] Association of increased basic salivary proline-rich protein 1 levels in induced sputum with type 2-high asthma
    Chen, Fengjia
    Liang, Yuxia
    Zeng, Zhimin
    Du, Lijuan
    Xu, Changyi
    Guo, Yubiao
    Xie, Canmao
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (04)
  • [32] Metabolomics, Microbiota, and In Vivo and In Vitro Biomarkers in Type 2 Severe Asthma: A Perspective Review
    Caruso, Cristiano
    Colantuono, Stefania
    Nicoletti, Alberto
    Arasi, Stefania
    Firinu, Davide
    Gasbarrini, Antonio
    Coppola, Angelo
    Di Michele, Loreta
    METABOLITES, 2021, 11 (10)
  • [33] Looking for Airways Periostin in Severe Asthma Could It Be Useful for Clustering Type 2 Endotype?
    Carpagnano, Giovanna E.
    Scioscia, Giulia
    Lacedonia, Donato
    Soccio, Piera
    Lepore, Giorgia
    Saetta, Marina
    Barbaro, Maria Pia Foschino
    Barnes, Peter J.
    CHEST, 2018, 154 (05) : 1083 - 1090
  • [34] Association of Corticosteroid Inhaler Type with Saliva Microbiome in Moderate-to-Severe Pediatric Asthma
    Alizadeh Bahmani, Amir Hossein
    Abdel-Aziz, Mahmoud I.
    Hashimoto, Simone
    Bang, Corinna
    Brandstetter, Susanne
    Corcuera-Elosegui, Paula
    Franke, Andre
    Gorenjak, Mario
    Harner, Susanne
    Kheiroddin, Parastoo
    Lopez-Fernandez, Leyre
    Neerincx, Anne H.
    Pino-Yanes, Maria
    Potocnik, Uros
    Sardon-Prado, Olaia
    Toncheva, Antoaneta A.
    Wolff, Christine
    Kabesch, Michael
    Kraneveld, Aletta D.
    Vijverberg, Susanne J. H.
    Maitland-van der Zee, Anke H.
    SysPharmPediA consortium
    BIOMEDICINES, 2025, 13 (01)
  • [35] Granulocyte-colony stimulating factor: Missing link for stratification of type 2-high and type 2-low chronic rhinosinusitis patients
    Van Nevel, Sharon
    Declercq, Jozefien
    Holtappels, Gabriele
    Lambrecht, Bart N.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (05) : 1655 - +
  • [36] Combination of monoclonal antibodies targeting type 2 inflammation for severe asthma and eosinophilic granulomatosis with polyangiitis
    Davanzo, Federica
    Marchi, Maria Rita
    Iorio, Luca
    Bortoli, Michela
    Doria, Andrea
    Padoan, Roberto
    AUTOIMMUNITY REVIEWS, 2024, 23 (03)
  • [37] Type-2-low severe asthma endotypes for new treatments: the new asthma frontier
    Chung, Kian Fan
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 23 (03) : 199 - 204
  • [38] Imbalanced Coagulation in the Airway of Type-2 High Asthma with Comorbid Obesity
    Womble, Jack T.
    McQuade, Victoria L.
    Ihrie, Mark D.
    Ingram, Jennifer L.
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 967 - 980
  • [39] Airway hyperresponsiveness to mannitol improves in both type 2 high and type 2 low asthma after specialist management
    Hvidtfeldt, Morten
    Sverrild, Asger
    Backer, Vibeke
    Porsbjerg, Celeste
    JOURNAL OF ASTHMA, 2021, 58 (09) : 1221 - 1228
  • [40] Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype
    Rabe, Klaus F.
    FitzGerald, J. Mark
    Bateman, Eric D.
    Castro, Mario
    Pavord, Ian D.
    Maspero, Jorge F.
    Busse, William W.
    Izuhara, Kenji
    Daizadeh, Nadia
    Ortiz, Benjamin
    Pandit-Abid, Nami
    Rowe, Paul J.
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (11) : 2916 - +
12345